Users' perspectives on bleeding patterns after two years of levonorgestrel-releasing intrauterine system use

Drugs in R and D

Volumn 3, Issue 6, 2002, Pages 387-391

  Nascimento, Roberta ^a   Bahamondes, Luis ^a   Hidalgo, Margarete ^a   Perrotti, Marcos ^a   Espejo Arce, Ximena ^a   Petta, Carlos Alberto ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

ADULT; AMENORRHEA; ARTICLE; BRAZIL; DRUG RELEASE; FEMALE; HUMAN; INTERVIEW; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENSTRUATION; OLIGOMENORRHEA; PARITY; PATIENT SATISFACTION; PRIORITY JOURNAL; SPOTTING;

EID: 0037965034     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200203060-00003     Document Type: Article

References (16)

1. Wildemeersch D, Schacht E, Thiery M, et al. Intrauterine contraception in the year 2001: can intrauterine device use be revived with new improved contraceptives technology? Eur J Contracept Reprod Health Care 2000; 5: 295-304
2. Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002; 57: 120-8
3. Stewart A, Cummins C, Gold L, et al. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001; 108: 74-86
4. Monteiro I, Bahamondes L, Diaz J, et al. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study. Contraception 2002; 65: 325-8
5. Hidalgo M, Bahamondes L, Perrotti M, et al. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002; 65: 129-32
6. Faundes A, Alvarez F, Diaz J. A Latin American experience with levonorgestrel IUD. Ann Med 1993; 25: 149-53
7. Diaz J, Bahamondes L, Monteiro I, et al. Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. Contraception 2000; 62: 59-61
8. Dda Silva MO, Costa MM. Reason, myths and fantasies: preliminary data and reflections about the Portuguese experience with LNG-IUS-induced hypomenorrhea. Eur J Contracept Reprod Health Care 1999; 4: 21-5
9. Backman T, Huhtala S, Blom T, et al. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. Br J Obstet Gynaecol 2000; 107: 335-9
10. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system: a follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999; 78: 716-21
11. Diaz J, Faundes A, Diaz M, et al. Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil. Contraception 1993; 47: 169-75
12. Suvisaari J, Lahteenmaki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception 1996; 54: 201-8
13. Chi IC, Farr G. The non-contraceptive effects of the levonorgestrel-releasing intrauterine device. Adv Contracept 1994; 10: 271-85
14. Ortayli N. User's perspectives on implantable contraceptives for women. Contraception 2002; 65: 107-11
15. Chimbira TH, Andrson A, Turnbull AC. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br J Obstet Gynaecol 1980; 87: 603-9
16. Backman T, Huhtala S, Luoto R, et al. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol 2002; 99: 608-13